10 pending office actions • 9 art units • 9 examiners • 0 of 10 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (60%) |
| §102 only | 1 (10%) |
| No statute on record | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUDSON, AMY ROSE | 2 | 75.1% | +11.4% |
| CARREIRO, CAITLIN ANN | 1 | 45.5% | +40.3% |
| BECCIA, CHRISTOPHER J | 1 | 83.4% | +14.0% |
| AEDER, SEAN E | 1 | 56.9% | +19.6% |
| SHIAO, YIH-HORNG | 1 | 72.6% | +75.6% |
| PARK, EVELYN GRACE | 1 | 54.2% | +45.8% |
| KENYON, JOHN S | 1 | 80.3% | +17.4% |
| KIM, TAEYOON | 1 | 51.5% | +51.4% |
| D' AMBROSIO, THEA | 1 | 55.6% | +56.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18113369 | DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS | KENYON, JOHN S | 19d |
| 18780198 | GUIDE DEVICE | BECCIA, CHRISTOPHER J | 62d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17602035 | Pharmaceutical Composition for Treating Muscle Disease | HUDSON, AMY ROSE | 79d overdue |
| 17906444 | HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID | HUDSON, AMY ROSE | 43d overdue |
| 18146109 | PRODUCTION METHOD FOR SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS AND PRODUCTION METHOD FOR CELL PREPARATION FOR JOINT MEDICAL TREATMENT | KIM, TAEYOON | 37d overdue |
| 17631934 | AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT | D' AMBROSIO, THEA | 5d overdue |
| 19108416 | ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA | CARREIRO, CAITLIN ANN | 3d overdue |
| 18256222 | Agent for Preventing or Treating Frontotemporal Lobar Degeneration | AEDER, SEAN E | 5d |
| 18128561 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM | PARK, EVELYN GRACE | 12d |
| 18113369 | DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS | KENYON, JOHN S | 19d |
| Art Unit | Apps |
|---|---|
| 1636 | 2 |
| 3786 | 1 |
| 3775 | 1 |
| 1642 | 1 |
| 1691 | 1 |
| 3791 | 1 |
| 1625 | 1 |
| 1631 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19108416 | ORAL USE OF AN IN-MOUTH WEARABLE DEVICE IN THE TREATMENT OF DYSPHAGIA | CARREIRO, CAITLIN ANN | 3786 | §103 | Non-Final OA | 3d overdue | Pending | Mar 03, 2025 |
| 18780198 | GUIDE DEVICE | BECCIA, CHRISTOPHER J | 3775 | §103 | Non-Final OA | 62d | Pending | Jul 22, 2024 |
| 18256222 | Agent for Preventing or Treating Frontotemporal Lobar Degeneration | AEDER, SEAN E | 1642 | Other | Non-Final OA | 5d | Pending | Jun 07, 2023 |
| 18254488 | POLYROTAXANE HAVING HYDROXY GROUP OR SULFO GROUP | SHIAO, YIH-HORNG | 1691 | §102 | Non-Final OA | 22d | Pending | May 25, 2023 |
| 18128561 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM | PARK, EVELYN GRACE | 3791 | §103 | Final Rejection | 12d | Pending | Mar 30, 2023 |
| 18113369 | DIAGNOSIS METHODS, DIAGNOSTIC AGENTS, AND THERAPEUTIC AGENTS AGAINST ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION, AND SCREENING METHODS FOR THESE AGENTS | KENYON, JOHN S | 1625 | §103 | Non-Final OA | 19d | Pending | Feb 23, 2023 |
| 18146109 | PRODUCTION METHOD FOR SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS AND PRODUCTION METHOD FOR CELL PREPARATION FOR JOINT MEDICAL TREATMENT | KIM, TAEYOON | 1631 | Other | Final Rejection | 37d overdue | Pending | Dec 23, 2022 |
| 17906444 | HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID | HUDSON, AMY ROSE | 1636 | Other | Non-Final OA | 43d overdue | Pending | Sep 15, 2022 |
| 17631934 | AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT | D' AMBROSIO, THEA | 1654 | §103 | Non-Final OA | 5d overdue | Pending | Jun 07, 2022 |
| 17602035 | Pharmaceutical Composition for Treating Muscle Disease | HUDSON, AMY ROSE | 1636 | §103 | Final Rejection | 79d overdue | Pending | Oct 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial